Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation

• Status: Completed
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This study investigates the role of azithromycin treatment for lymphocytic bronchitis/bronchiolitis after lung transplantation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Katholieke Universiteit Leuven; KU Leuven
• Collaborator: Fund for Scientific Research, Flanders, Belgium
• Treatments: Azithromycin

Criteria

Inclusion Criteria:

• Signed informed consent

• Adult (age at least 18 years old at moment of transplantation)

• Able to take oral medication

• Histologic diagnosis of lymphocytic bronchiolitis or bronchitis ('grade B') without concurrent acute cellular allograft rejection 'grade A' ≥2

Exclusion Criteria:

• Severe suture problems (e.g. airway stenosis) requiring lasering or stenting